United States - English - NLM (National Library of Medicine)

carr & day & martin international ltd - petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u), sassafras oil (unii: 78zx2pfg2z) (sassafras oil - unii:78zx2pfg2z) - petrolatum 731 g in 1 l - for daily maintenance unique cornucrescine formulation maintains optimum hoof health nourishes and protects

United States - English - NLM (National Library of Medicine)

carr & day & martin limited - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox), .alpha.-tocopherol (unii: h4n855pnz1) (.alpha.-tocopherol - unii:h4n855pnz1), cetostearyl alcohol (unii: 2dmt128m1s) (cetostearyl alcohol - unii:2dmt128m1s) - glycerin 100 g in 1 l - formulated specifically to achieve optimum moisture replacement for dry and brittle hooves.  prolonged dry periods can cause the hoof horn to dehydrate and in severe cases result in cracking and splitting.

United States - English - NLM (National Library of Medicine)

carr & day & martin limited - petrolatum (unii: 4t6h12bn9u) (petrolatum - unii:4t6h12bn9u), sassafras oil (unii: 78zx2pfg2z) (sassafras oil - unii:78zx2pfg2z) - petrolatum 731 g in 1 l - to maintain healthy growth of horn apply weekly or more frequently if required. also suitable to nourish and help bald patches, rubbed areas or scars.

United States - English - NLM (National Library of Medicine)

carr & day & martin, international ltd - tea tree oil (unii: vif565uc2g) (tea tree oil - unii:vif565uc2g) - tea tree oil 22 g in 1 l - tea tree hoof oil contains a specially selected blend of oils to provide anti-bacterial and anti-fungal protection.  used on a regular basis it will maintain and protect hooves keeping them in first class condition and leave a show ring shine.

United States - English - NLM (National Library of Medicine)

carr & day & martin limited - white spirit type 1 (unii: 37lnj1i16r) (white spirit type 1 - unii:37lnj1i16r), turpentine (unii: xj6ruh0o4g) (turpentine - unii:xj6ruh0o4g) - white spirit type 1 950 g in 1 l - daily hoof barrier creates a protective "one-way barrier" allowing the hoof to both breathe and repel excess moisture.  excellent for use in wet and muddy conditions or prolonged stabling which if damp underfoot can adversely affect both hoof health and shoe retention.

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin 150 mg in 1 ml - cleocin phosphate products are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. cleocin phosphate products are also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of antibiotic-associated pseudomembranous colitis, as described in the boxed warning , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g. erythromycin). bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin. indicated surgical procedures should be performed in conjunction with antibiotic therapy. cleocin phosphate is indicated in the treatment of serious infections caused by susceptible strains of designated or

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - cleocin phosphate products are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. cleocin phosphate products are also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of antibiotic-associated pseudomembranous colitis, as described in the boxed warning , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin. indicated surgical procedures should be performed in conjunction with antibiotic therapy. cleocin phosphate is indicated in the treatment of serious infections caused by susceptible strains of

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - cleocin phosphate products are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. cleocin phosphate products are also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of antibiotic-associated pseudomembranous colitis, as described in the boxed warning , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin. indicated surgical procedures should be performed in conjunction with antibiotic therapy. cleocin phosphate is indicated in the treatment of serious infections caused by susceptible strains of

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - cleocin phosphate products are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. cleocin phosphate products are also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of antibiotic-associated pseudomembranous colitis, as described in the boxed warning , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin. indicated surgical procedures should be performed in conjunction with antibiotic therapy. cleocin phosphate is indicated in the treatment of serious infections caused by susceptible strains of

United States - English - NLM (National Library of Medicine)

henry schein, inc. - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - cleocin phosphate products are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. cleocin phosphate products are also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. because of the risk of antibiotic-associated pseudomembranous colitis, as described in the boxed warning , before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin. indicated surgical procedures should be performed in conjunction with antibiotic therapy. cleocin phosphate is indicated in the treatment of serious infections caused by susceptible strains of the designat